Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results

Back

ESC Premium Access

Discussant review: Cardiovascular OutcoMes for People using Anticoagulation StrategieS (COMPASS) trial: Primary Results

Session: Hot Line: Late-Breaking Clinical Trials 1

Topic: Primary cardiovascular prevention: interventions and outcomes

Speaker: Professor E. Braunwald (Boston, US)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Professor Eugene Braunwald

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

37 presentations

13 followers

14 more presentations in this session

Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study

Speaker: Professor I. Van Gelder (Groningen, NL)

Discussant review: Routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure, the RACE 3 study.

Speaker: Professor J. Brugada Terradellas (Barcelona, ES)

Panel discussion.

Access

Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor N. Marrouche (New Orleans, US)

Discussant review: Catheter ablation versus standard conventional treatment in patients with left ventricular dysfunction and atrial fibrillation: the CASTLE-AF trial

Speaker: Professor M. Blomstrom-Lundqvist (Orebro, SE)

Access the full session

Hot Line: Late-Breaking Clinical Trials 1

Speakers: Professor E. Braunwald, Professor I. Van Gelder, Professor J. Brugada Terradellas, Professor N. Marrouche, Professor M. Blomstrom-Lundqvist

Access

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources